|
|
Promedior - Innately Superior Therapeutics for Fibrosis
Tags:
promedior,
fibrosis,
therapeutics,
innately,
superior,
approach,
novel,
announces,
pentraxin,
clinical,
new,
fibrotic,
study,
asthma,
anti,
patients,
therapeutic,
prm,
pulmonary,
research,
publication,
sap,
demonstrating,
potent,
inhibitor,
events,
news,
initiation,
cells,
induced,
lung,
initiates,
phase,
idiopathic,
ipf,
post,
design,
prevention,
series,
digizyme,
Promedior.com
Content Revalency:
Title: 50.00%
Description: 0.00%
Keywords: 0.00% | Document size: 7,842 bytes
More info:
Whois -
Trace Route -
RBL Check
| PROMEDIOR.COM - Site Location |
| Country/Flag |
 United States |
| City/Region/Zip Code |
Scottsdale, AZ, 85260 |
| Organization |
GoDaddy.com, LLC |
| Internet Service Provider |
GoDaddy.com, LLC |
|
PROMEDIOR.COM - Domain Information |
| Domain |
PROMEDIOR.COM [ Traceroute RBL/DNSBL lookup ] |
| Registrar |
Oracle America, Inc. New Frontier, Inc. |
| Whois server |
whois.verisign-grs.com |
| Created |
30-Oct-2006 |
| Updated |
17-Dec-2019 |
| Expires |
18-Apr-2021 |
| Time Left |
0 days 0 hours 0 minutes |
| Status |
clientTransferProhibited https://icann.org/epp#clientTransferProhibited clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited |
| DNS servers |
NS1.P30.DYNECT.NET 208.78.70.30
NS2.P30.DYNECT.NET 204.13.250.30
NS3.P30.DYNECT.NET 208.78.71.30
NS4.P30.DYNECT.NET 204.13.251.30
ns2.p30.dynect.net 204.13.250.30
ns4.p30.dynect.net 204.13.251.30
ns1.p30.dynect.net 208.78.70.30
ns3.p30.dynect.net 208.78.71.30
|
| PROMEDIOR.COM - DNS Information |
| IP Address |
97.74.215.7 ~ Whois - Trace Route - RBL Check
|
| Domain Name Servers |
ns32.domaincontrol.com 173.201.73.16
ns31.domaincontrol.com 97.74.105.16
|
| Mail Exchange |
promedior.com.s8a1.psmtp.com
promedior.com.s8a2.psmtp.com
promedior.com.s8b1.psmtp.com
promedior.com.s8b2.psmtp.com
|
| Site Response Header |
| Response |
HTTP/1.1 200 OK |
| Server |
Microsoft-IIS/7.0 |
| Date |
Sat, 16 Apr 2011 01:10:42 GMT |
| Content-Type |
text/html |
|
